Mediterranean Journal of Hematology and Infectious Diseases
短名 | Mediterr J Hematol Infect Dis |
Journal Impact | 1.85 |
国际分区 | INFECTIOUS DISEASES(Q3) |
期刊索引 | SCI Q2中科院 4 区 |
ISSN | 2035-3006 |
h-index | 40 |
国内分区 | 医学(4区)医学血液学(4区)医学传染病学(4区) |
众所周知,传染性疾病和血液疾病(恶性和非恶性)之间相互依赖。这种关系在地中海国家尤为明显。寄生虫病如疟疾、利什曼病、B 钩虫病、丝虫病,在地中海东南部地区非常常见,感染了大约 10 亿人,并普遍表现为贫血,因此通常由经验丰富的血液学家通过血液或骨髓涂片诊断。另一方面,感染也是受血液系统恶性肿瘤影响的患者的一个重要问题。血液是 HIV 感染的主要载体,否则会出现与 T 淋巴细胞减少相关的症状。反过来,感染可能有利于血液系统恶性肿瘤的发生。 EPSTEIN-BARR 病毒感染、幽门螺杆菌、丙型肝炎病毒、HIV 和淋巴组织增生性疾病之间的因果关系是众所周知的。
期刊主页投稿网址涉及主题 | 医学生物内科学病理遗传学免疫学外科化学生物化学疾病心理学精神科儿科胃肠病学基因 |
出版信息 | 出版商: Universita Cattolica del Sacro Cuore,出版周期: ,期刊类型: journal |
基本数据 | 创刊年份: 2010,原创研究文献占比: 71.70%,自引率:5.00%, Gold OA占比: 98.00% |
平均审稿周期 | 网友分享经验:12 Weeks |
期刊引文格式
这些示例是对学术期刊文章的引用,以及它们应该如何出现在您的参考文献中。
并非所有期刊都按卷和期组织其已发表的文章,因此这些字段是可选的。有些电子期刊不提供页面范围,而是列出文章标识符。在这种情况下,使用文章标识符而不是页面范围是安全的。
只有1位作者的期刊
有2位作者的期刊
有3位作者的期刊
有5位以上作者的期刊
书籍引用格式
以下是创作和编辑的书籍的参考文献的示例。
学位论文引用格式
网页引用格式
这些示例是对网页的引用,以及它们应该如何出现在您的参考文献中。
专利引用格式
最新文章
ANTIBIOTIC LOCK THERAPY FOR PORT CATHETER-RELATED INFECTIONS OF CHILDREN WITH ACUTE LEUKEMIA
2024-8-31
MPN/MDS overlap syndrome anticipated by a severe bleeding diathesis: hypothesis of a pre-existing platelet disorder
2024-8-31
BLINATUMOMAB IN THE THERAPY OF ACUTE B-LYMPHOID LEUKEMIA
2024-8-31
CD146 MOLECULE EXPRESSION IN B CELLS ACUTE LYMPHOBLASTIC LEUKEMIA (B-ALLs): A FLOW- CYTOMETRIC MARKER FOR AN ACCURATE DIAGNOSTIC WORK-UP
2024-8-31
Feasibility and outcome of first-line autotransplant-based treatment in newly diagnosed multiple myeloma patients aged > 65 years: monocentric retrospective real-world analysis
2024-8-31
THERAPEUTIC GENE EDITING FOR HEMOGLOBINOPATHIES
2024-8-31
ANORECTAL PATHOLOGIES IN THE COURSE OF ACUTE LEUKAEMIAS; PREDICTIVE PARAMETERS.
2024-8-31
Hb H disease caused by uniparental disomy: first report of the αT-Saudiα mutation in the Chinese population
2024-8-31
UPDATE ON CYTOMEGALOVIRUS INFECTION MANAGEMENT IN ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANT RECIPIENTS.
2024-8-31
EFFECTS OF DARATUMUMAB ON HEMATOPOIETIC STEM CELLS IN PATIENTS WITH MULTIPLE MYELOMA WHO ARE PLANNED TO RECEIVE AUTOLOGOUS TRANSPLANTATION: WHAT’S THE RELEVANCE?
2024-8-31
Is there a better therapeutic time window from diagnosis to treatment elderly acute myeloid leukemia patients receiving hypomethylating agents?
2024-6-29
Waldenström Macroglobulinemia - A State-of-the-Art Review: Part 1: Epidemiology, pathogenesis, clinicopathologic characteristics, differential diagnosis, risk stratification, and clinical problems.
2024-6-29
Atypical differentiation syndrome with sudden vision loss in acute promyelocytic leukemia treated with ATRA plus ATO: a clinical case.
2024-6-29
Transcriptome analysis of beta-catenin-related genes in CD34+ haematopoietic stem and progenitor cells from patients with AML
2024-6-29
IMMUNE THROMBOTIC THROMBOCYTOPENIC PURPURA: PATHOPHYSIOLOGY, DIAGNOSIS AND OPEN ISSUES.
2024-6-29
Association of rheumatoid arthritis with glucose- 6-phosphate dehydrogenase deficiency—results from a case-control study
2024-6-29
Low incidence of anti-PF4/heparin antibodies in patients with acute myelogenous leukaemia
2024-6-29
RECENT ADVANCES IN THE DEFINITION OF THE MOLECULAR ALTERATIONS OCCURRING IN MULTIPLE MYELOMA
2024-6-29
Expression of oxidative stress and inflammatory indicators for coronary artery disease in Kawasaki disease
2024-6-29
IMPORTANCE OF SOURCE CONTROL IN THE SUBGROUP OF INTRA-ABDOMINAL INFECTIONS FOR SEPTIC SHOCK PATIENTS: ANALYSIS OF 390 CASES.
2024-6-29
Hyperbilirubinemia in ABO minor mismatch transplantation
2024-6-29
HODGKIN LYMPHOMA IN CHILDREN: A 16-YEAR EXPERIENCE AT THE CHILDREN’S WELFARE TEACHING HOSPITAL OF BAGHDAD, IRAQ.
2024-6-29
A case of congenital dyserythropoietic anemia masked by hemoglobin H disease
2024-6-29
ACUTE LEUKEMIA AND LATENT TUBERCULOSIS INFECTION IN ITALY: QUANTIFERON-TB TEST SCREENING IN A LOW TUBERCULOSIS INCIDENCE COUNTRY
2024-6-29
Impact of the Addition of Daratumumab to the Standard Bortezomib-Thalidomide-Dexamethasone Regimen on Hematopoietic Stem Cell Mobilization and Collection, Post-Transplant Engraftment and Infectious Complications: A Case-Control Multicentre Real-Life Analy
2024-4-30
CAR-T CELLS IN CHRONIC LYMPHOCYTIC LEUKEMIA
2024-4-30
CLINICAL CARE PATHWAY AND MANAGEMENT OF MAJOR BLEEDING ASSOCIATED WITH NON-VITAMIN K ANTAGONIST ORAL ANTICOAGULANTS: A MODIFIED DELPHI CONSENSUS FROM SAUDI ARABIA AND UAE
2024-4-30
LETERMOVIR PRIMARY CYTOMEGALOVIRUS PROPHYLAXIS IN ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANT RECIPIENTS: COULD INFECTION AND DISEASE NO LONGER BE A SIGNIFICANT PROBLEM?
2024-4-30
Antivirals and monoclonal antibody combination therapy in haematological patients in the omicron era
2024-4-30
Impact of daratumumab on stem cell mobilization and transplant in patient with newly diagnosed multiple myeloma: a real word single-center study
2024-4-30
Very late onset Post-Transplantation Lymphoproliferative Disorder (PTLD) after haematopoietic stem cell transplant (HCT) – A Clinical Case
2024-4-30
Outcome of Allogeneic Hematopoietic Stem Cell Transplantation in a Child with Myelodysplastic Neoplasm with Complex Karyotype and ETV6 Variant: Challenges in Treatment
2024-4-30
HAPLOIDENTICAL HEMATOPOIETIC STEM CELL TRANSPLANTATION FOR PAEDIATRIC PATIENTS WITH X-LINKED LYMPHOPROLIFERATIVE SYNDROME
2024-4-30
Evaluation of VTE-PREDICT risk score in patients receiving low-dose DOACs for venous thromboembolism (VTE) secondary prophylaxis
2024-4-30
LYMPHOCYTES IN PATIENTS WITH CHRONIC ACTIVE EPSTEIN-BARR VIRUS INFECTION EXHIBITED ELEVATED PD-1/PD-L1 EXPRESSION AND A PREVAILING TH2 IMMUNE RESPONSE.
2024-4-30
EBV-RELATED LYMPHOPROLIFERATIVE DISEASES: A REVIEW IN LIGHT OF NEW CLASSIFICATIONS
2024-4-30
IS IT POSSIBLE TO PREDICT TUMOR PROGRESSION THROUGH GENOMIC CHARACTERIZATION OF MONOCLONAL GAMMOPATHY AND SMOLDERING MULTIPLE MYELOMA?
2024-4-30
CLINICAL AND LABORATORY FEATURES OF SICKLE CELL DISEASE S/D PUNJAB: IMPACT OF HBF AND HYDROXYUREA
2024-4-30
Congress abstract
2024-3-27
CAR-T CELL THERAPY FOR T-CELL MALIGNANCIES
2024-2-29
Could the 3′UTR+101G>C Mutation Detected in Two Sibling Cases Be a Mutation Affecting the Clinical Presentation in Thalassemia Patients?
2024-2-29
FLT3 Mutated Acute Myeloid Leukemia after CD19 CAR-T Cells
2024-2-29
Rituximab versus Splenectomy in Chronic Primary ITP: Experience of a Single Hematology Clinic
2024-2-29
Antibody response to breakthrough SARS-CoV-2 infection in “booster” vaccinated patients with multiple myeloma according to B/T/NK lymphocyte absolute counts and anti-CD38 treatments
2024-2-29
Coexistence of multiple gene variants in some patients with erythrocytoses
2024-2-29
Secondary prophylaxis of venous thromboembolism (VTE) with low dose apixaban or rivaroxaban: results from a patient population with more than 2 years of median follow-up
2024-2-29
Protein S deficiency with recurrent thromboembolism in a patient with hemoglobin H disease following splenectomy
2024-2-29
Plasmablastic Lymphoma. A State-of-the-Art Review: Part 2-Focus on therapy
2024-2-29
Clinical signs and treatment of New-onset Bone marrow failure associated SARS-CoV-2 infection in Children : a single institution prospective cohort study .
2024-2-29
Pneumatosis cystoides intestinalis with fatal air embolism after minor blunt abdominal trauma in a 6-year-old girl undergoing hematopoietic stem cell trasplant: case report and review of literature
2024-2-29
帮你贴心管理全部的文献
研飞ivySCI,高效的论文管理
投稿经验分享
分享我的经验,帮你走得更远